We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+5.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.1B
AUM Growth
+$362M
(+1.1%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
15.48%
Holding
3,181
New
192
Increased
947
Reduced
1,799
Closed
170
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$22.1M |
| 2 |
General Motors
GM
|
+$15.6M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$11.2M |
| 4 |
Micron Technology
MU
|
+$11.1M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$63.9M |
| 2 |
Microsoft
MSFT
|
+$31.4M |
| 3 |
IBM
IBM
|
+$23.4M |
| 4 |
ExxonMobil
XOM
|
+$23M |
| 5 |
Pfizer
PFE
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 14.25% |
| 3 | Healthcare | 13.21% |
| 4 | Industrials | 11.1% |
| 5 | Energy | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
MGIC Investment
MTG
$6.44B
| $3.61M | 0.01% |
390,958
+18,792
| +5% | +$163K |
|
|
MPT
977
Medical Properties Trust
MPT
$2.81B
| $3.61M | 0.01% |
272,749
+11,227
| +4% | +$149K |
|
978
ONE Gas
OGS
$4.9B
| $3.61M | 0.01% |
95,527
+18,445
| +24% | +$675K |
|
|
ROC
979
DELISTED
ROCKWOOD HLDGS INC
ROC
| $3.6M | 0.01% |
47,438
-11,916
| -20% | -$876K |
|
|
FCS
980
DELISTED
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
| $3.6M | 0.01% |
230,671
+62,336
| +37% | +$879K |
|
|
QGENF
981
DELISTED
QIAGEN NV
QGENF
| $3.6M | 0.01% |
147,056
+6,971
| +5% | +$170K |
|
|
LTC
982
LTC Properties
LTC
$2.06B
| $3.59M | 0.01% |
92,023
+12,227
| +15% | +$477K |
|
983
Wintrust Financial
WTFC
$10.8B
| $3.59M | 0.01% |
78,024
+2,828
| +4% | +$128K |
|
|
MDP
984
DELISTED
Meredith Corporation
MDP
| $3.58M | 0.01% |
74,070
-6,782
| -8% | -$308K |
|
985
Chemed
CHE
$7.1B
| $3.57M | 0.01% |
38,135
-4,905
| -11% | -$435K |
|
|
NPSP
986
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $3.56M | 0.01% |
107,822
-14,531
| -12% | -$420K |
|
987
Tidewater
TDW
$3.65B
| $3.56M | 0.01% |
1,966
-206
| -9% | -$342K |
|
|
DCT
988
DELISTED
DCT Industrial Trust Inc.
DCT
| $3.56M | 0.01% |
108,379
+1,502
| +1% | +$47.4K |
|
|
AKRX
989
DELISTED
Akorn Inc
AKRX
| $3.56M | 0.01% |
106,921
+132
| +0.1% | +$3.46K |
|
|
CPHD
990
DELISTED
Cepheid Inc
CPHD
| $3.55M | 0.01% |
74,119
-1,598
| -2% | -$72.5K |
|
991
CoStar Group
CSGP
$12B
| $3.55M | 0.01% |
224,250
-94,000
| -30% | -$1.52M |
|
992
Silicon Laboratories
SLAB
$7.15B
| $3.55M | 0.01% |
72,028
+11,317
| +19% | +$538K |
|
|
CAB
993
DELISTED
Cabela's Inc
CAB
| $3.55M | 0.01% |
56,843
-13,205
| -19% | -$837K |
|
|
HOUS
994
DELISTED
Anywhere Real Estate
HOUS
| $3.54M | 0.01% |
93,864
+4,401
| +5% | +$171K |
|
995
Cousins Properties
CUZ
$5.25B
| $3.53M | 0.01% |
100,426
+17,818
| +22% | +$597K |
|
996
Bio-Rad Laboratories Class A
BIO
$8.74B
| $3.52M | 0.01% |
29,423
-1,906
| -6% | -$233K |
|
997
Pebblebrook Hotel Trust
PEB
$2.12B
| $3.52M | 0.01% |
95,274
-1,053
| -1% | -$37K |
|
|
BIG
998
DELISTED
Big Lots, Inc.
BIG
| $3.52M | 0.01% |
76,988
-10,119
| -12% | -$411K |
|
|
MDRX
999
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.52M | 0.01% |
219,167
-7,914
| -3% | -$123K |
|
|
DBD
1000
DELISTED
Diebold Nixdorf Incorporated
DBD
| $3.52M | 0.01% |
87,579
-137
| -0.2% | -$5.26K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2014 Portfolio in Review
As of Q2 2014, RhumbLine Advisers held 3,181 positions worth $34.1B, up 1.1% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers withdrew a net $1.11B in Q2 2014, closing 170 positions and reducing 1,799 holdings. Its most notable exit was BEAM INC COM STK (DE), an estimated $18.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in Navient worth $10M.
- RhumbLine Advisers's largest Q2 2014 buy was Navient: 566,289 shares worth $10M.
- RhumbLine Advisers added most to American Airlines Group in Q2 2014, an estimated $22.1M increase.
- RhumbLine Advisers's biggest Q2 2014 reduction was Apple, cutting an estimated $63.9M.
- RhumbLine Advisers fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $18.3M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.1B portfolio in Q2 2014.
- RhumbLine Advisers opened 192 new positions and closed 170 in Q2 2014.
- RhumbLine Advisers's portfolio value rose 1.1% quarter-over-quarter to $34.1B.
Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.